ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $63,000 | -16.0% | 49,550 | +126.0% | 0.00% | 0.0% |
| Q2 2019 | $75,000 | -31.2% | 21,923 | +1.7% | 0.00% | -50.0% |
| Q1 2019 | $109,000 | +41.6% | 21,558 | +0.9% | 0.00% | +100.0% |
| Q4 2018 | $77,000 | -36.9% | 21,358 | +2.5% | 0.00% | -50.0% |
| Q3 2018 | $122,000 | – | 20,838 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 3,278,000 | $11,834,000 | 0.90% |
| Senvest Management, LLC | 2,124,393 | $7,669,000 | 0.66% |
| DELTEC ASSET MANAGEMENT LLC | 351,176 | $1,268,000 | 0.35% |
| PERKINS CAPITAL MANAGEMENT INC | 99,600 | $360,000 | 0.28% |
| Matarin Capital Management, LLC | 838,619 | $3,027,415,000 | 0.24% |
| GLOBEFLEX CAPITAL L P | 196,357 | $709,000 | 0.17% |
| Opaleye Management Inc. | 120,000 | $433,000 | 0.16% |
| TSP Capital Management Group, LLC | 49,175 | $178,000 | 0.10% |
| Spark Investment Management LLC | 373,609 | $1,348,000 | 0.09% |
| Connor, Clark & Lunn Investment Management Ltd. | 3,191,964 | $11,523,000 | 0.08% |